Services Sector Stocks Touching New Highs: American Airlines Group (NASDAQ:AAL), Southwest Airlines (NYSE:LUV), McClatchy (NYSE:MNI), United Rentals (NYSE:URI)
The U.S. Justice Department said on Monday that American Airlines Group made $425 million by selling take-off and landing slots at two busy East Coast airports, as required to win approval for the merger that set up the company. American Airlines Group Inc. (NASDAQ:AAL) stock performance was -0.15% in last session and finished the day at $38.96. Traded volume was 11.42 million shares in the … Continue reading Services Sector Stocks Touching New Highs: American Airlines Group (NASDAQ:AAL), Southwest Airlines (NYSE:LUV), McClatchy (NYSE:MNI), United Rentals (NYSE:URI)
Biotech Stocks Touching New Highs: Northwest Biotherapeutics (NASDAQ:NWBO), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Emergent Biosolutions (NYSE:EBS), Xencor (NASDAQ:XNCR)
CRT Capital Thursday morning ratings report included a coverage initiation by analyst Arlinda Lee on Oncogenex Pharmaceuticals (NASDAQ: OGXI) with a Buy rating and price target of $20. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) rose 8.88 percent to $13.85 yesterday on volume of 483,342million shares. The intra-day range of the stock was $12.61 to $13.95. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) has a market capitalization of $203.70million. Emergent Biosolutions … Continue reading Biotech Stocks Touching New Highs: Northwest Biotherapeutics (NASDAQ:NWBO), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Emergent Biosolutions (NYSE:EBS), Xencor (NASDAQ:XNCR)
Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)
German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small US biotechnology company has not yet completed its late-stage trial of the immunotherapy. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at $7.85. Traded volume was 6,155,092 million shares in the last … Continue reading Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)
Health Net (NYSE:HNT) Reaffirms Guidance; Perfect World (NASDAQ:PWRD), Wright Medical Group Inc. (NASDAQ:WMGI), Douglas Dynamics (NYSE:PLOW)
Health Net (NYSE:HNT), a managed care company, disclosed in a regulatory filing Monday that it will be reaffirming its earnings guidance for fiscal 2014 at the Barclays Global Healthcare Conference on Tuesday. The company had previously said that it is expecting fiscal 2014 earnings of at least $3.00 per share and revenue of $14.4 billion. Analysts polled by Capital IQ are expecting EPS of $2.39 … Continue reading Health Net (NYSE:HNT) Reaffirms Guidance; Perfect World (NASDAQ:PWRD), Wright Medical Group Inc. (NASDAQ:WMGI), Douglas Dynamics (NYSE:PLOW)
Boyd Gaming (NYSE:BYD) Surges After Hours; Hill International (NYSE:HIL), Atlas Financial Holdings Inc. (NASDAQ:AFH), Summit Midstream Partners, LP (NYSE:SMLP), American Eagle Energy (NYSEMKT:AMZG)
Boyd Gaming (NYSE:BYD) is surging in after-hours trading after activist hedge fund Elliott Associates disclosed a stake in the casino operator. In a filing with the SEC, Elliott disclosed it owns 4.99% of Boyd’s outstanding common stock, with a 2.05% exposure to common shares via derivatives. Elliott said its combined economic exposure to Boyd (NYSE:BYD) is 7%, with its voting power in the company coming … Continue reading Boyd Gaming (NYSE:BYD) Surges After Hours; Hill International (NYSE:HIL), Atlas Financial Holdings Inc. (NASDAQ:AFH), Summit Midstream Partners, LP (NYSE:SMLP), American Eagle Energy (NYSEMKT:AMZG)
Pharma in Focus After Hours: Kythera (NASDAQ:KYTH), La Jolla Pharmaceutical (NASDAQ:LJPC), Medifast (NYSE:MED)
Kythera (NASDAQ:KYTH) and Bayer ADR (OTCMRKTS:BAYRY) announced that Kythera acquired all rights outside of the U.S. and Canada to ATX-101, a proprietary formulation of a purified synthetic version of deoxycholic acid currently in late-stage development for the reduction of submental fat (double chin). In 2010, KYTHERA (NASDAQ:KYTH) licensed the commercial rights to ATX-101 outside of the U.S. and Canada to Bayer Consumer Care AG. Under … Continue reading Pharma in Focus After Hours: Kythera (NASDAQ:KYTH), La Jolla Pharmaceutical (NASDAQ:LJPC), Medifast (NYSE:MED)
